Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 3 I, 2000, Pages 967-972

  Pääkkö, Paavo ^a   Kaarteenaho Wiik, Riitta ^a   Pöllänen, Raimo ^a   Soini, Ylermi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CYTOKERATIN; MESSENGER RNA; TENASCIN;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROBLAST; LUNG INJURY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL;

EID: 0343570029     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.3.9809115     Document Type: Article

References (33)

1. Cherniack, R. M., T. V. Colby, A. Flint, W. M. Thurlbeck, J. Waldron, L. Ackerson, T. E. King, Jr., and the BAL Cooperative Group Steering Committee. 1991. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 144:892-900.
2. Katzenstein, A.-L. A., and J. L. Myers. 1998. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. State of the art. Am. J. Respir. Crit. Care Med. 157:1301-1315.
3. Bjoraker, J. A., J. H. Ryu, M. K. Edwin, J. L. Myers, H. D. Tazelaar, D. R. Schroeder, and K. P. Offord. 1998. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 157:199-203.
4. Chiquet, M., and D. M. Fambrough. 1984. Chick myotendinous antigen: II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J. Cell Biol. 98:1937-1946.
5. Erickson, H. P. 1993. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol 5:869-876.
6. Hagios, C., M. Koch, J. Spring, M. Chiquet, and R. Chiquet-Ehrismann. 1996. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue. J. Cell Biol. 134: 1499-1512.
7. Chiquet-Ehrismann, R. 1990. What distinguishes tenascin from fibronectin? FASEB J. 4:2598-2604.
8. Erickson, H. P., and M. A. Bourdon. 1989. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol 5:71-92.
9. Koukoulis, G. K., V. E. Gould, A. Bhattacharyya, J. E. Gould, A. A. Howeedy, and I. Virtanen. 1991. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum. Pathol. 22:636-643.
10. Koch, M., B. Wehrle-Haller, S. Baumgartner, J. Spring, D. Brubacher, and M. Chiquet. 1991. Epithelial synthesis of tenascin at tips of growing bronchi and graded accumulation in basement membrane and mesenchyme. Exp. Cell Res. 194:297-300.
11. Young, S. L., L.-Y. Chang, and H. P. Erickson. 1994. Tenascin-C in rat lung: distribution, ontogeny and role in branching morphogenesis. Dev. Biol. 161:615-625.
12. Soini, Y., P. Pääkkö, K. Nuorva, D. Kamel, A. Linnala, I. Virtanen, and V.-P. Lehto. 1993. Tenascin immunoreactivity in lung tumors. Am. J. Clin. Pathol. 100:145-150.
13. Wallace, W. A. H., S. E. M. Howie, D. Lamb, and D. M. Salter. 1995. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis. J. Pathol. 175:415-420.
14. Kaarteenaho-Wiik, R., T. Tani, R. Sormunen, Y. Soini, I. Virtanen, and P. Pääkkö. 1996. Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 154:511-518.
15. 1-anti-trypsin gene to the lung epithelium in vivo. Science 252:431-434.
16. Siri, A., B. Carnemolla, M. Saginati, A. Leprini, G. Casari, F. Baralle, and L. Zardi. 1991. Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucleic Acids Res. 19:525-531.
17. Pääkkö, P., K. Nuorva, D. Kamel, and Y. Soini. 1992. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. Am. J. Respir. Cell Mol. Biol. 7:325-334.
18. Kuhn, C., and J. A. McDonald. 1991. The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 138:1257-1265.
19. Mattey, D. L., P. T. Dawes, N. B. Nixon, and H. Slater. 1997. Transforming growth factor β1 and interleukin 4 induced α smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann. Rheum. Dis. 56:426-431.
20. Yokozeki, M., K. Moriyama, H. Shimokawa, and T. Kuroda. 1997. Transforming growth factor-β1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro. Exp. Cell Res. 231:328-336.
21. Pearson, C. A., D. Pearson, S. Shibahara, J. Hofsteenge, and R. Chiquet-Ehrismann. 1988. Tenascin: cDNA cloning and induction by TGF-β. EMBO J. 7:2977-2982.
22. Härkönen, E., I. Virtanen, A. Linnala. L. L. Laitinen, and V. L. Kinnula. 1995. Modulation of fibroneclin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. Am. J. Respir. Cell Mol. Biol. 13:109-115.
23. Linnala, A., V. Kinnula, L. A. Laitinen, V.-P. Lehto, and I. Virtanen. 1995. Transforming growth factor-β regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 13:578-585.
24. Kinnula, V. L., A. Linnala, E. Viitala, K. Linnainmaa, and I. Virtanen. 1998. Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells. Am. J. Respir. Cell Mol. Biol. 19:445-452.
25. Latijnhouwers, M., M. ecgers, M. Ponec, H. Dijkman, and M. Andriessen. 1997. Human epidermal keratinocytes are a source of tenascin-C during wound healing. J. Invest. Dermatol. 108:776-783.
26. Tuominen H., R. Pöllänen, and M. Kallioinen. 1997. Multicellular origin of tenascin in skin tumors - an in situ hybridization study. J. Cutan. Pathol. 24:590-596.
27. Soini, Y., R. Pöllanen, H. Autio-Harmainen, and V.-P. Lehto. 1997. Tenascin expression in lichen sclerosus. Int. J. Gynecol. Pathol. 16:313-318.
28. Yoshida, T., E.-I. Matsumoto, N. Hanamura, I. Kalembeyi, K. Katsuta, A. Ishihara, and T. Sakakura. 1997. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J. Pathol. 182:421-428.
29. Hanamura, N., T. Yoshida, E.-I. Matsumoto, Y. Kawarada, and T. Sakakura. 1997. Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular ceils and epithelial cells in human colon adenomas and carcinomas. Int. J. Cancer 73:10-15.
30. Corrin, B., and A. Dewar. 1996. Pathogenesis of idiopathic interstitial pulmonary fibrosis. Ultrastruct. Pathol. 20:369-371.
31. 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 24:145-150.
32. Zhang, K., K. C. Flanders, and S. H. Phan. 1995. Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147:352-361.
33. 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 150:981-991.